<p>EP Wealth Advisors LLC 在第一季度将其在美敦力公司（NYSE:MDT - 免费报告）的持股增加了 163.9%，根据其最近向证券交易委员会（SEC）提交的 13F 文件。该公司在季度内购买了 21,221 股后，持有 34,165 股这家医疗技术公司的股票。根据其最近向证券交易委员会（SEC）提交的文件，EP Wealth Advisors LLC 在美敦力的持股价值为 3,070,000 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
<p>其他一些机构投资者最近也买卖了该公司的股票。Brighton Jones LLC 在第四季度将其在美敦力的持股增加了 1,368.0%。Brighton Jones LLC 现在拥有 39,989 股这家医疗技术公司的股票，价值 3,194,000 美元，在上个季度又购买了 37,265 股。Bridgefront Capital LLC 在第四季度购买了美敦力的新头寸，价值约为 277,000 美元。CoreCap Advisors LLC 在第四季度将其在美敦力的持股增加了 16.8%。CoreCap Advisors LLC 现在拥有 2,244 股这家医疗技术公司的股票，价值 179,000 美元，在上个季度又购买了 322 股。Diligent Investors LLC 在第四季度将其在美敦力的持股增加了 3.2%。Diligent Investors LLC 现在拥有 9,616 股这家医疗技术公司的股票，价值 768,000 美元，在上个季度又购买了 300 股。最后，德意志银行（Deutsche Bank AG）在第四季度将其在美敦力的持股增加了 2.1%。德意志银行现在拥有 18,443,640 股这家医疗技术公司的股票，价值 1,473,278,000 美元，在此期间又购买了 372,168 股。机构投资者持有该公司 82.06% 的股票。</p>
<h2>美敦力价格表现</h2>
<p>美敦力（MDT）股票周四开盘价为 92.20 美元。该公司的市值为 1182.6 亿美元，市盈率为 25.40，PEG 比率为 2.36，贝塔值为 0.77。该公司的 50 日移动平均线为 90.71 美元，200 日移动平均线为 88.09 美元。美敦力的 12 个月低点为 79.29 美元，12 个月高点为 96.25 美元。该公司的速动比率为 1.42，流动比率为 2.01，债务权益比率为 0.54。</p>
<ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
<p>美敦力（NYSE:MDT - 获取免费报告）最近于 8 月 19 日（星期二）发布了季度财报。这家医疗技术公司报告本季度每股收益为 1.26 美元，超出市场共识预期的 1.23 美元，超出 0.03 美元。美敦力的股本回报率为 14.61%，净利润率为 13.63%。该公司本季度的收入为 85.8 亿美元，而分析师预期为 83.7 亿美元。在去年同期，该公司每股收益为 1.23 美元。该公司本季度的收入同比增长了 7.7%。美敦力已将其 2026 财年的指引设定为 5.600-5.660 每股收益。研究分析师预计美敦力将在当前财年发布 5.46 每股收益。</p>
<h2>美敦力股息公告</h2>
<p>该公司最近还宣布了一项季度股息，将于 10 月 17 日（星期五）支付。9 月 26 日（星期五）登记的股东将获得每股 0.71 美元的股息。这相当于年化股息为 2.84 美元，股息收益率为 3.1%。该股息的除息日期为 9 月 26 日（星期五）。美敦力的股息支付比率目前为 78.24%。</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>5 只未来自动化的机器人股票</li>
</ul>
<p>一些券商对 MDT 发表了评论。瑞银集团（UBS Group）在 8 月 20 日（星期三）的研究报告中将美敦力的目标价从 94.00 美元上调至 95.00 美元，并给予该股票 “中性” 评级。威廉·布莱尔（William Blair）在 7 月 11 日（星期五）的研究报告中将美敦力的评级上调至 “持有”。瑞穗（Mizuho）在 7 月 16 日（星期三）的研究报告中将美敦力的目标价从 98.00 美元上调至 100.00 美元，并给予该股票 “跑赢大盘” 评级。BTIG 研究在 7 月 11 日（星期五）的研究报告中重申了对美敦力股票的 “中性” 评级。最后，花旗集团（Citigroup）在 8 月 21 日（星期四）的研究报告中将美敦力的目标价从 99.00 美元上调至 101.00 美元，并给予该公司 “买入” 评级。一位研究分析师对该股票给予了强烈买入评级，十位分析师给予了买入评级，八位分析师给予了持有评级。根据 MarketBeat.com 的数据，美敦力目前的共识评级为 “适度买入”，共识目标价为 102.14 美元。</p>
<p><strong>查看我们关于美敦力的最新研究报告</strong></p>
<h2>内部活动</h2>
<p>在其他美敦力的新闻中，董事 William R. Jellison 于 8 月 25 日（星期一）购买了 2,500 股该股票。每股平均购买成本为 92.37 美元，总价值为 230,925.00 美元。完成收购后，该董事直接持有该公司 5,000 股，价值 461,850 美元。这笔交易代表了其持股的 100.00% 增长。该交易已在向 SEC 提交的文件中披露，相关文件可通过此链接访问。当前内部人士持有该股票的 0.26%。</p>
<h2>美敦力公司简介</h2>
<p>（免费报告）</p>
<p>美敦力公司开发、制造和销售基于设备的医疗疗法，面向全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供植入式心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票，而不是美敦力</li>
<li>3 只天然气股票，提供优厚的股息收益</li>
<li>开学购物达到 400 亿美元：现在值得关注的 3 只零售股票</li>
<li>市盈率计算：如何评估股票</li>
<li>谷歌母公司股票在躲避严厉的反垄断措施后大幅上涨</li>
<li>三只值得购买和持有的医疗保健股息股票</li>
<li>为什么高通在经历数月滞后后表现优于英伟达</li>
</ul>
<p><strong>想知道其他对美敦力感兴趣的对冲基金持有哪些股票吗？</strong> 访问 HoldingsChannel.com 获取美敦力 PLC (NYSE:MDT - 免费报告) 的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在美敦力吗？</h2>
<p>在考虑美敦力之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛的市场注意到之前立即购买的股票……而美敦力并不在名单上。</p>
<p>虽然美敦力目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美敦力

<p>EP Wealth Advisors LLC 在第一季度将其在美敦力（Medtronic PLC）的持股增加了 163.9%，增持了 21,221 股，总持股达到 34,165 股，市值为 307 万美元。其他机构投资者也增加了他们的持股。美敦力报告第一季度每股收益为 1.26 美元，超出预期，营收为 85.8 亿美元。公司宣布每股季度分红为 0.71 美元，收益率为 3.1%。分析师对该股票的评级不一，普遍目标价为 102.14 美元</p>

<p>EP Wealth Advisors LLC raised its holdings in Medtronic PLC (NYSE:MDT - Free Report) by 163.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,165 shares of the medical technology company's stock after purchasing an additional 21,221 shares during the quarter. EP Wealth Advisors LLC's holdings in Medtronic were worth $3,070,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>EP Wealth Advisors LLC 在第一季度将其在美敦力公司（NYSE:MDT - 免费报告）的持股增加了 163.9%，根据其最近向证券交易委员会（SEC）提交的 13F 文件。该公司在季度内购买了 21,221 股后，持有 34,165 股这家医疗技术公司的股票。根据其最近向证券交易委员会（SEC）提交的文件，EP Wealth Advisors LLC 在美敦力的持股价值为 3,070,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
</div><p>A number of other institutional investors have also recently bought and sold shares of the business. Brighton Jones LLC lifted its holdings in Medtronic by 1,368.0% during the 4th quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company's stock worth $3,194,000 after purchasing an additional 37,265 shares in the last quarter. Bridgefront Capital LLC purchased a new position in shares of Medtronic during the 4th quarter valued at about $277,000. CoreCap Advisors LLC raised its holdings in shares of Medtronic by 16.8% during the 4th quarter. CoreCap Advisors LLC now owns 2,244 shares of the medical technology company's stock valued at $179,000 after buying an additional 322 shares in the last quarter. Diligent Investors LLC raised its holdings in shares of Medtronic by 3.2% during the 4th quarter. Diligent Investors LLC now owns 9,616 shares of the medical technology company's stock valued at $768,000 after buying an additional 300 shares in the last quarter. Finally, Deutsche Bank AG increased its stake in Medtronic by 2.1% in the 4th quarter. Deutsche Bank AG now owns 18,443,640 shares of the medical technology company's stock worth $1,473,278,000 after purchasing an additional 372,168 shares during the period. Institutional investors own 82.06% of the company's stock.</p>
<div class="lb-trans"><p>其他一些机构投资者最近也买卖了该公司的股票。Brighton Jones LLC 在第四季度将其在美敦力的持股增加了 1,368.0%。Brighton Jones LLC 现在拥有 39,989 股这家医疗技术公司的股票，价值 3,194,000 美元，在上个季度又购买了 37,265 股。Bridgefront Capital LLC 在第四季度购买了美敦力的新头寸，价值约为 277,000 美元。CoreCap Advisors LLC 在第四季度将其在美敦力的持股增加了 16.8%。CoreCap Advisors LLC 现在拥有 2,244 股这家医疗技术公司的股票，价值 179,000 美元，在上个季度又购买了 322 股。Diligent Investors LLC 在第四季度将其在美敦力的持股增加了 3.2%。Diligent Investors LLC 现在拥有 9,616 股这家医疗技术公司的股票，价值 768,000 美元，在上个季度又购买了 300 股。最后，德意志银行（Deutsche Bank AG）在第四季度将其在美敦力的持股增加了 2.1%。德意志银行现在拥有 18,443,640 股这家医疗技术公司的股票，价值 1,473,278,000 美元，在此期间又购买了 372,168 股。机构投资者持有该公司 82.06% 的股票。</p>
</div><h2>Medtronic Price Performance</h2>
<div class="lb-trans"><h2>美敦力价格表现</h2>
</div><p>Shares of MDT stock opened at $92.20 on Thursday. The stock has a market cap of $118.26 billion, a price-to-earnings ratio of 25.40, a PEG ratio of 2.36 and a beta of 0.77. The business's fifty day moving average is $90.71 and its 200 day moving average is $88.09. Medtronic PLC has a twelve month low of $79.29 and a twelve month high of $96.25. The company has a quick ratio of 1.42, a current ratio of 2.01 and a debt-to-equity ratio of 0.54.</p>
<div class="lb-trans"><p>美敦力（MDT）股票周四开盘价为 92.20 美元。该公司的市值为 1182.6 亿美元，市盈率为 25.40，PEG 比率为 2.36，贝塔值为 0.77。该公司的 50 日移动平均线为 90.71 美元，200 日移动平均线为 88.09 美元。美敦力的 12 个月低点为 79.29 美元，12 个月高点为 96.25 美元。该公司的速动比率为 1.42，流动比率为 2.01，债务权益比率为 0.54。</p>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last issued its quarterly earnings results on Tuesday, August 19th. The medical technology company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.23 by $0.03. Medtronic had a return on equity of 14.61% and a net margin of 13.63%.The company had revenue of $8.58 billion for the quarter, compared to analysts' expectations of $8.37 billion. During the same period in the prior year, the firm earned $1.23 earnings per share. The firm's revenue for the quarter was up 7.7% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.600-5.660 EPS. Research analysts expect that Medtronic PLC will post 5.46 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT - 获取免费报告）最近于 8 月 19 日（星期二）发布了季度财报。这家医疗技术公司报告本季度每股收益为 1.26 美元，超出市场共识预期的 1.23 美元，超出 0.03 美元。美敦力的股本回报率为 14.61%，净利润率为 13.63%。该公司本季度的收入为 85.8 亿美元，而分析师预期为 83.7 亿美元。在去年同期，该公司每股收益为 1.23 美元。该公司本季度的收入同比增长了 7.7%。美敦力已将其 2026 财年的指引设定为 5.600-5.660 每股收益。研究分析师预计美敦力将在当前财年发布 5.46 每股收益。</p>
</div><h2>Medtronic Dividend Announcement</h2>
<div class="lb-trans"><h2>美敦力股息公告</h2>
</div><p>The firm also recently declared a quarterly dividend, which will be paid on Friday, October 17th. Stockholders of record on Friday, September 26th will be issued a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date of this dividend is Friday, September 26th. Medtronic's dividend payout ratio is presently 78.24%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度股息，将于 10 月 17 日（星期五）支付。9 月 26 日（星期五）登记的股东将获得每股 0.71 美元的股息。这相当于年化股息为 2.84 美元，股息收益率为 3.1%。该股息的除息日期为 9 月 26 日（星期五）。美敦力的股息支付比率目前为 78.24%。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><ul>
<li>5 Robotics Stocks to Buy for the Future of Automation</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只未来自动化的机器人股票</li>
</ul>
</div><p>A number of brokerages have commented on MDT. UBS Group lifted their price target on Medtronic from $94.00 to $95.00 and gave the stock a &#34;neutral&#34; rating in a research note on Wednesday, August 20th. William Blair raised Medtronic to a &#34;hold&#34; rating in a research note on Friday, July 11th. Mizuho lifted their price target on Medtronic from $98.00 to $100.00 and gave the stock an &#34;outperform&#34; rating in a research note on Wednesday, July 16th. BTIG Research reaffirmed a &#34;neutral&#34; rating on shares of Medtronic in a research note on Friday, July 11th. Finally, Citigroup boosted their target price on Medtronic from $99.00 to $101.00 and gave the company a &#34;buy&#34; rating in a research note on Thursday, August 21st. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, Medtronic currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $102.14.</p>
<div class="lb-trans"><p>一些券商对 MDT 发表了评论。瑞银集团（UBS Group）在 8 月 20 日（星期三）的研究报告中将美敦力的目标价从 94.00 美元上调至 95.00 美元，并给予该股票 “中性” 评级。威廉·布莱尔（William Blair）在 7 月 11 日（星期五）的研究报告中将美敦力的评级上调至 “持有”。瑞穗（Mizuho）在 7 月 16 日（星期三）的研究报告中将美敦力的目标价从 98.00 美元上调至 100.00 美元，并给予该股票 “跑赢大盘” 评级。BTIG 研究在 7 月 11 日（星期五）的研究报告中重申了对美敦力股票的 “中性” 评级。最后，花旗集团（Citigroup）在 8 月 21 日（星期四）的研究报告中将美敦力的目标价从 99.00 美元上调至 101.00 美元，并给予该公司 “买入” 评级。一位研究分析师对该股票给予了强烈买入评级，十位分析师给予了买入评级，八位分析师给予了持有评级。根据 MarketBeat.com 的数据，美敦力目前的共识评级为 “适度买入”，共识目标价为 102.14 美元。</p>
</div><p><strong>View Our Latest Research Report on Medtronic</strong></p>
<div class="lb-trans"><p><strong>查看我们关于美敦力的最新研究报告</strong></p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><p>In other Medtronic news, Director William R. Jellison purchased 2,500 shares of the stock in a transaction dated Monday, August 25th. The shares were purchased at an average cost of $92.37 per share, with a total value of $230,925.00. Following the completion of the acquisition, the director directly owned 5,000 shares in the company, valued at $461,850. This trade represents a 100.00% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.26% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在其他美敦力的新闻中，董事 William R. Jellison 于 8 月 25 日（星期一）购买了 2,500 股该股票。每股平均购买成本为 92.37 美元，总价值为 230,925.00 美元。完成收购后，该董事直接持有该公司 5,000 股，价值 461,850 美元。这笔交易代表了其持股的 100.00% 增长。该交易已在向 SEC 提交的文件中披露，相关文件可通过此链接访问。当前内部人士持有该股票的 0.26%。</p>
</div><h2>Medtronic Company Profile</h2>
<div class="lb-trans"><h2>美敦力公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p>
<div class="lb-trans"><p>美敦力公司开发、制造和销售基于设备的医疗疗法，面向全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供植入式心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>3 Natural Gas Stocks That Offer Great Dividend Yields</li>
<li>Back-to-School Shopping Hits $40B: 3 Retail Stocks to Watch Now</li>
<li>P/E Ratio Calculation: How to Assess Stocks</li>
<li>Alphabet Stock Surges After Dodging Harsh Antitrust Remedies</li>
<li>The Top 3 Healthcare Dividend Stocks to Buy and Hold</li>
<li>Why Qualcomm Is Outperforming NVIDIA After Months of Lagging</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是美敦力</li>
<li>3 只天然气股票，提供优厚的股息收益</li>
<li>开学购物达到 400 亿美元：现在值得关注的 3 只零售股票</li>
<li>市盈率计算：如何评估股票</li>
<li>谷歌母公司股票在躲避严厉的反垄断措施后大幅上涨</li>
<li>三只值得购买和持有的医疗保健股息股票</li>
<li>为什么高通在经历数月滞后后表现优于英伟达</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他对美敦力感兴趣的对冲基金持有哪些股票吗？</strong> 访问 HoldingsChannel.com 获取美敦力 PLC (NYSE:MDT - 免费报告) 的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在美敦力吗？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑美敦力之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛的市场注意到之前立即购买的股票……而美敦力并不在名单上。</p>
</div><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然美敦力目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

EP Wealth Advisors LLC 收购了美敦力 PLC 的 21,221 股 $MDT